Similar articles for PMID: 21139092

Year	Number of Results
1994	1
1996	1
2002	2
2003	3
2004	3
2005	2
2006	2
2007	1
2008	1
2009	3
2010	7
2011	10
2012	12
2013	11
2014	11
2015	9
2016	10
2017	10
2018	9
2019	3
2020	2
2021	8
2022	12
2023	4
2024	0

1

Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation.

Eckman MH, Singer DE, Rosand J, Greenberg SM. Eckman MH, et al. Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):14-21. doi: 10.1161/CIRCOUTCOMES.110.958108. Epub 2010 Dec 7. Circ Cardiovasc Qual Outcomes. 2011. PMID: 21139092 Free PMC article.

2

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.

Oldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ; RE-LY Investigators. Oldgren J, et al. Ann Intern Med. 2011 Nov 15;155(10):660-7, W204. doi: 10.7326/0003-4819-155-10-201111150-00004. Ann Intern Med. 2011. PMID: 22084332 Clinical Trial.

3

Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.

Casciano JP, Singer DE, Kwong WJ, Fox ES, Martin BC. Casciano JP, et al. Am J Cardiovasc Drugs. 2012 Oct 1;12(5):313-23. doi: 10.1007/BF03261840. Am J Cardiovasc Drugs. 2012. PMID: 22920047

4

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.

Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Freeman JV, et al. Ann Intern Med. 2011 Jan 4;154(1):1-11. doi: 10.7326/0003-4819-154-1-201101040-00289. Epub 2010 Nov 1. Ann Intern Med. 2011. PMID: 21041570 Free article.

5

The net clinical benefit of warfarin anticoagulation in atrial fibrillation.

Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. Singer DE, et al. Ann Intern Med. 2009 Sep 1;151(5):297-305. doi: 10.7326/0003-4819-151-5-200909010-00003. Ann Intern Med. 2009. PMID: 19721017 Free PMC article.

6

Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.

Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H, Terasaki T, Yoshimura S, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Nagakane Y, Kameda T, Hasegawa Y, Shibuya S, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Matsuki T, Homma K, Takasugi J, Tokunaga K, Sato S, Kario K, Kitazono T, Toyoda K; SAMURAI Study Investigators. Arihiro S, et al. Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29. Int J Stroke. 2016. PMID: 26927811 Free article.

7

Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.

Janzic A, Kos M. Janzic A, et al. Pharmacoeconomics. 2015 Apr;33(4):395-408. doi: 10.1007/s40273-014-0246-7. Pharmacoeconomics. 2015. PMID: 25512096

8

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Jacobs LG, et al. Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002. Am J Geriatr Pharmacother. 2009. PMID: 19616184

9

Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.

Agarwal S, Hachamovitch R, Menon V. Agarwal S, et al. Arch Intern Med. 2012 Apr 23;172(8):623-31; discussion 631-3. doi: 10.1001/archinternmed.2012.121. Epub 2012 Mar 26. Arch Intern Med. 2012. PMID: 22450212 Review.

10

Factors associated with ischemic stroke on therapeutic anticoagulation in patients with nonvalvular atrial fibrillation.

Kim YD, Lee KY, Nam HS, Han SW, Lee JY, Cho HJ, Kim GS, Kim SH, Cha MJ, Ahn SH, Oh SH, Lee KO, Jung YH, Choi HY, Han SD, Lee HS, Nam CM, Kim EH, Lee KJ, Song D, Park HN, Heo JH. Kim YD, et al. Yonsei Med J. 2015 Mar;56(2):410-7. doi: 10.3349/ymj.2015.56.2.410. Yonsei Med J. 2015. PMID: 25683989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

120 results

Results by year